- Phosphodiesterase inhibitors - a new promise in the tratment of COPD?2010 | Second Faculty of Medicine
- Apremilast -small molecule with the substantial therapeutical impact on the inflammation in patients with immunopathological disorders2019 | Faculty of Medicine in Hradec Králové
- Roflumilast in the context of new guidelines for treatment of chronic obstructive pulmonary disease2014 | Faculty of Medicine in Hradec Králové
- Apremilast, the new drug with complex impact on inflammation in patients with psoriasis and psoriatic arthritis2016 | Faculty of Medicine in Hradec Králové
- Position of roflumilast in Czech recommendations for treatment of stable chronic obstructive pulmonary disease2015 | Faculty of Medicine in Hradec Králové
- Indications and effectiveness of anti-inflammatory therapy in COPD roflumilast2013 | Second Faculty of Medicine
- New treatment options for chronic inflammation associated with COPD2011 | Second Faculty of Medicine
- Roflumilast a dušnost u pacientů se středně těžkou až velmi těžkou chronickou obstrukční plicní nemocí2014 | Third Faculty of Medicine